Revelation and reference from successful experience of artemisinin to tuberculosis prevention and control

doi:10.19983/j.issn.2096-8493.20230089

Abstract

Abstract:

The discovery of artemisinin-based antimalarial drugs is a milestone in the history of global antimalarial drug development. It is a major accomplishment achieved by the multi-departmental and multidisciplinary cooperation and mutual cooperation under the organization of scientific research programs, and is a successful example of inheriting and carrying forward the treasure house of traditional medicine in China. Learning the measures of successful experience in artemisinin research and development and drawing experience is important for improving the status quo of tuberculosis preventive treatment, promoting and improving the current tuberculosis prevention and control measures in China, and will play a beneficial role in promoting the goal of ending tuberculosis epidemic as scheduled.

Key words: Artemisinins, Tuberculosis, pulmonary, Thinking

CLC Number:

Cao Yuqing, Shang Xiyu, Xiong Yibai, Ji Xinyu, Ma Yan. Revelation and reference from successful experience of artemisinin to tuberculosis prevention and control[J]. Journal of Tuberculosis and Lung Disease , 2023, 4(6): 442-448. doi: 10.19983/j.issn.2096-8493.20230089

Figures/Tables 1

References 45

[1]	TU Y. Artemisinin-A Gift from Traditional Chinese Medicine to the World (Nobel Lecture). Angew Chem Int Ed Engl, 2016, 55(35):10210-10226. doi:10.1002/anie.201601967.
[2]	Bourzac K. Infectious disease: Beating the big three. Nature, 2014, 507(7490):S4-S7. doi:10.1038/507s4a.
[3]	World Health Organization. World malaria report 2022. Geneva: World Health Organization, 2022.
[4]	中国疟疾的防治与研究编委会. 中国疟疾的防治与研究. 北京: 人民卫生出版社, 1991.
[5]	World Health Organization. Global tuberculosis report 2022. Geneva: World Health Organization, 2022.
[6]	肖和平, 刘一典. 新型冠状病毒肺炎疫情防控机制对结核病防治的启示. 中国防痨杂志, 2020, 42(4):311-315. doi:10.3969/j.issn.1000-6621.2020.04.003.
[7]	赵飞, 杜昕, 李涛, 等. 基于世界卫生组织公共数据库的中国结核病流行趋势与预测. 临床药物治疗杂志, 2018, 16(4):1-3,8. doi:10.3969/j.issn.1672-3384.2018.04.001.
[8]	饶立歆, 沈鑫. 携手并进终结结核病终结艾滋病. 结核与肺部疾病杂志, 2022, 3(6):429-430. doi:10.19983/j.issn.2096-8493.20220162.
[9]	Cox FE. History of the discovery of the malaria parasites and their vectors. Parasit Vectors, 2010, 3(1):5. doi:10.1186/1756-3305-3-5. pmid: 20205846
[10]	卢义钦. 青蒿素的发现与研究进展. 生命科学研究, 2012, 16(3):260-265. doi:10.16605/j.cnki.1007-7847.2012.03.012.
[11]	刘霁堂, 凌子平. 青蒿素发明的历史追踪及启示. 新中医, 2018, 50(3):1-5. doi:10.13457/j.cnki.jncm.2018.03.001.
[12]	张剑方. 迟到的报告. 广州: 羊城晚报出版社, 2006.
[13]	黎润红, 张大庆. 青蒿素:从中国传统药方到全球抗疟良药. 中国科学院院刊, 2019, 34(9):1046-1057. doi:10.16418/j.issn.1000-3045.2019.09.009.
[14]	徐国恒. 青蒿素发现历程的介绍与再认识. 生物学通报, 2016, 51(3):1-6.
[15]	屠呦呦. 青蒿及青蒿素类药物. 北京: 化学工业出版社, 2009.
[16]	刘源隆. 屠呦呦:青蒿素,送给世界的礼物. 小康, 2018 (36):56-57.
[17]	张翮. 青蒿素发现史研究的回顾和思考. 中华医史杂志, 2018, 48(2):114-118. doi:10.3760/cma.j.issn.0255-7053.2018.02.006.
[18]	刘霁堂, 李燕君. 523精神与青蒿素发明. 中国中医药现代远程教育, 2018, 16(4):24-27. doi:10.3969/j.issn.1672-2779.2018.04.009.
[19]	朱安远. 青蒿素之母——诺贝尔奖得主屠呦呦. 世界科学, 2022 (8):54-57.
[20]	TU YY. The discovery of artemisinin (qinghaosu) and gifts from Chinese medicine. Nature Medicne, 2011, 17 (10):1217-1220.
[21]	青蒿素结构研究协作组. 一种新型的倍半萜内酯——青蒿素. 科学通报, 1977, 22(3):142.
[22]	李国桥, 李英, 李泽琳, 等. 青蒿素类抗疟药. 北京: 科学出版社, 2015.
[23]	李舒养, 黄剑, 吴祖祥, 等. 黄花素生产工艺的研究. 中草药通讯, 1979, 12:555-559
[24]	刘静明, 倪慕云, 樊菊芬, 等. 青蒿素的结构和反应. 化学学报, 1979, 37(2):129-140.
[25]	Uskokovi MR, Williams TH, Blount JF. The structure and absolute configuration of arteannuin B. Hely Chim Acta, 1974, 57(3):600-602. doi: 10.1002/hlca.v57:3 URL
[26]	中医研究院中药研究所药理研究室. 青蒿的药理研究. 新医药学杂志, 1979, 1:23-33.
[27]	赵一, 李爱媛, 周芳. 青蒿素抗疟作用原理与增效的探讨. 广西中医药, 1978, 2(3):52.
[28]	李锐, 李秀挺, 龙达翔, 等. 青蒿素药理作用初步研究(二). 新中医, 1980, 12(1):37.
[29]	四川省中药研究所药理室. 青蒿素的药理研究. 四川医学, 1980, 1(1):33-36.
[30]	Peters W, James DM, Li ZL, et al. Antimalarial acfivity of Arteannuin (Artemisinime, Oinghaosu), a Chinese plant deriveative, against Plasmodium berghei: preliminary data. Transaction of the Royal Society of Tropical Medicine and Hygiene, 1981, 75(4):603-604.
[31]	China cooperative research group on Qinghaosu and its derivatives as antimalarials. Antimalarial efficacy and mode of action of Oinghaosu and its derivatives in experimental models. J Trad Chin Med, 1982, 2(1):17-24.
[32]	Li ZL, Gu HM, Warhurst DC, et al. Effects of qinghaosu and related compounds on incorporation of (G-3H hypoxanthine byPlasmodium falciparum in vitro. Transaction of the Royal Society of Tropical Medicine and Hygiene, 1983, 77(4):522-523. doi: 10.1016/0035-9203(83)90129-3 URL
[33]	中国科学院上海药物研究所抗疟研究组. 青蒿素衍生物的化学合成和药理研究. 医药工业, 1979, 10(1):30. doi:10.16522/j.cnki.cjph.1979.01.007.
[34]	李锐, 龙达翔, 李秀挺, 等. 青蒿素药理初步研究(一). 新中医, 1979, 11(6):51.
[35]	赵一, 李小娟, 李爱媛, 等. 青蒿素的毒性试验报告. 广西中医药, 1979, 3(1):45-46.
[36]	China cooperative research group. Studies on the toxicity of qinghaosu and its derivatives. J Trad Chin Med, 1982, 2(1):31-38.
[37]	王德文, 关明臣, 刘雪桐. 恒河猴肌注青素亚急性毒性病理学研究. 解放军医学杂志, 1983, 8(4):257-260.
[38]	王德文, 刘雪桐. 青蒿素对猴心肌超微结构的影响. 军事医学科学院院刊, 1982, 7(4):459-463.
[39]	China Cooperative Research Group on Oinghaosu and its Derivatives as Antimalarials. Metabolism and pharmacokinetics of qinghaosu and its derivatives. J Trad Chin Med, 1982, 2(1):25-30.
[40]	臧其中, 齐尚斌, 万尧德. 3H-青蒿素在动物体内的吸收、分布和排泄. 四川医学, 1980, 1(1):30.
[41]	广东海南抗疟临床研究协作组. 青蒿素治疗抗氯喹疟疾65例的效果观察. 新医药学杂志, 1979(1):12-16.
[42]	李国桥. 青蒿素治疗凶险型恶性疟48例临床报告. 新医药学杂志, 1979(1):17-20.
[43]	张大庆, 黎润红, 饶毅. 继承与创新:五二三任务与青蒿素研发. 北京: 中国科学技术出版社, 2017.
[44]	杨博, 孙毅凡, 雷瑶, 等. 青蒿素及其衍生物治疗疟疾的研究进展. 中国寄生虫学与寄生虫病杂志, 2021, 39(3):393-402. doi:10.12140/j.issn.1000-7423.2021.03.016.
[45]	World Health Organization. From 30 million cases to zero: China is certified malaria-free by WHO. Geneva: World Health Organization, 2021.